122 related articles for article (PubMed ID: 12950541)
21. Use of sedation during cardioversion with the implantable atrial defibrillator.
Timmermans C; Nabar A; Rodriguez LM; Ayers G; Wellens HJ
Circulation; 1999 Oct; 100(14):1499-501. PubMed ID: 10510051
[TBL] [Abstract][Full Text] [Related]
22. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
[TBL] [Abstract][Full Text] [Related]
23. Rapid atrial pacing does not decrease the atrial defibrillation threshold.
Frykman V; Darpo B; Ayers GM; Bergfeldt L; Linde C; Rosenqvist M
Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 1):1461-6. PubMed ID: 12914622
[TBL] [Abstract][Full Text] [Related]
24. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
[TBL] [Abstract][Full Text] [Related]
25. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.
Tompkins CM; McNitt S; Polonsky B; Daubert JP; Wang PJ; Moss AJ; Zareba W; Kutyifa V
J Cardiovasc Electrophysiol; 2017 Jan; 28(1):94-102. PubMed ID: 27696593
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation.
Sra JS; Maglio C; Dhala A; Blanck Z; Biehl M; Deshpande S; Keelan ET; Jazayeri MR; Akhtar M
J Am Coll Cardiol; 1996 Nov; 28(6):1532-8. PubMed ID: 8917268
[TBL] [Abstract][Full Text] [Related]
27. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam.
Fabian TJ; Schwartzman DS; Ujhelyi MR; Corey SE; Bigos KL; Pollock BG; Kroboth PD
J Cardiovasc Electrophysiol; 2006 Apr; 17(4):391-5. PubMed ID: 16643361
[TBL] [Abstract][Full Text] [Related]
28. Left atrial mechanical function after brief duration atrial fibrillation.
Sparks PB; Jayaprakash S; Mond HG; Vohra JK; Grigg LE; Kalman JM
J Am Coll Cardiol; 1999 Feb; 33(2):342-9. PubMed ID: 9973013
[TBL] [Abstract][Full Text] [Related]
29. Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds.
Gold MR; Shorofsky SR; Bouhouch R; Joy RA; Kirby DS; Osman AF; Rashba EJ
J Cardiovasc Electrophysiol; 2002 Apr; 13(4):332-5. PubMed ID: 12033348
[TBL] [Abstract][Full Text] [Related]
30. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
[TBL] [Abstract][Full Text] [Related]
31. Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks.
Boriani G; Biffi M; Zannoli R; Branzi A; Magnani B
Int J Cardiol; 1999 Sep; 71(1):63-9. PubMed ID: 10522566
[TBL] [Abstract][Full Text] [Related]
32. Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator.
Tse HF; Timmermans C; Rodriguez LM; Lau CP; Wellens HJ
J Cardiovasc Electrophysiol; 2003 Jan; 14(1):32-7. PubMed ID: 12625607
[TBL] [Abstract][Full Text] [Related]
33. Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2).
Boodhoo L; Mitchell A; Ujhelyi M; Sulke N
Pacing Clin Electrophysiol; 2004 Jul; 27(7):910-7. PubMed ID: 15271009
[TBL] [Abstract][Full Text] [Related]
34. Internal atrial defibrillation: effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers.
Prakash A; Saksena S; Mathew P; Krol RB
Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 1):2434-41. PubMed ID: 9358485
[TBL] [Abstract][Full Text] [Related]
35. Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation.
Ricci R; Quesada A; Pignalberi C; Roda J; Disertori M; Capucci A; Raviele A; Santini M
J Interv Card Electrophysiol; 2004 Feb; 10(1):85-92. PubMed ID: 14739755
[TBL] [Abstract][Full Text] [Related]
36. Transvenous single lead atrial defibrillation: efficacy and risk of ventricular fibrillation in an ischemic canine model.
Osswald S; Trouton TG; Roelke M; O'Nunain SS; Fallon JT; Holden HB; Ruskin JN; Garan H
Pacing Clin Electrophysiol; 1998 Mar; 21(3):580-9. PubMed ID: 9558691
[TBL] [Abstract][Full Text] [Related]
37. Initial clinical experience with an implantable human atrial defibrillator.
Lau CP; Tse HF; Lok NS; Lee KL; Ho DS; Sopher M; Murgatroyd F; Camm AJ
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):220-5. PubMed ID: 9121994
[TBL] [Abstract][Full Text] [Related]
38. Quality of life after use of the patient activated atrial defibrillator.
Spurrell P; Mitchell A; Kamalvand K; Sulke N
Int J Clin Pract; 2003; 57(1):30-4. PubMed ID: 12587939
[TBL] [Abstract][Full Text] [Related]
39. Nocturnal phantom shock cessation with zolpidem.
House LM; McKay RE; Eagan JT; McCormick ZL
Heart Lung; 2018; 47(1):76-79. PubMed ID: 29128111
[TBL] [Abstract][Full Text] [Related]
40. Defibrillation efficacy and pain perception of two biphasic waveforms for internal cardioversion of atrial fibrillation.
Jung J; Hahn SJ; Heisel A; Buob A; Schubert BD; Siaplaouras S
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):837-40. PubMed ID: 12890046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
